<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Orthop Traumatol</journal-id><journal-id journal-id-type="iso-abbrev">J Orthop Traumatol</journal-id><journal-id journal-id-type="pmc-domain-id">844</journal-id><journal-id journal-id-type="pmc-domain">jortr</journal-id><journal-title-group><journal-title>Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology</journal-title></journal-title-group><issn pub-type="ppub">1590-9921</issn><issn pub-type="epub">1590-9999</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474814</article-id><article-id pub-id-type="pmcid-ver">PMC12474814.1</article-id><article-id pub-id-type="pmcaid">12474814</article-id><article-id pub-id-type="pmcaiid">12474814</article-id><article-id pub-id-type="pmid">41003870</article-id><article-id pub-id-type="doi">10.1186/s10195-025-00874-7</article-id><article-id pub-id-type="publisher-id">874</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Soft tissue reconstruction of tumor-related proximal tibial hemiarthroplasty using synthetic mesh combined with a medial gastrocnemius flap</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zhuoyu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="J">Jilong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fan</surname><given-names initials="D">Daoyang</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Deng</surname><given-names initials="Z">Zhiping</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="Y">Yongkun</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Niu</surname><given-names initials="X">Xiaohui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Q">Qing</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Liu</surname><given-names initials="W">Weifeng</given-names></name><address><email>liuweifengjst@126.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02v51f717</institution-id><institution-id institution-id-type="GRID">grid.11135.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2256 9319</institution-id><institution>Department of Orthopaedic Oncology Surgery, </institution><institution>Peking University Fourth School of Clinical Medicine, </institution></institution-wrap>Beijing, 100035 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/013xs5b60</institution-id><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Department of Orthopaedic Oncology Surgery, National Center for Orthopedics, </institution><institution>Beijing Jishuitan Hospital, Capital Medical University, </institution></institution-wrap>Beijing, 100035 China </aff><aff id="Aff3"><label>3</label>Beijing Research Institute of Traumatology and Orthopaedics, Beijing, 100035 China </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2025</year></pub-date><volume>26</volume><issue-id pub-id-type="pmc-issue-id">478259</issue-id><elocation-id>58</elocation-id><history><date date-type="received"><day>19</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 14:25:15.427"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10195_2025_Article_874.pdf"/><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">This study was to evaluate the efficacy of soft tissue reconstruction using synthetic mesh and a medial gastrocnemius flap in patients who underwent proximal tibial hemiarthroplasty after resection of proximal tibial bone sarcomas.</p></sec><sec><title>Methods</title><p id="Par2">A retrospective cohort study was conducted on 102 skeletally immature children (58 males, 44 females) who underwent proximal tibial Hemiarthroplasty between January 2005 and December 2023. The most common diagnoses were osteosarcoma (95%), Ewing&#8217;s sarcoma (4%), and chondrosarcoma (1%). The mean age was 11&#160;years (7&#8211;14&#160;years) and the mean follow-up was 85&#160;months (12&#8211;233&#160;months). We reported complications according to the modified Henderson classification. The functional outcomes were evaluated by Musculoskeletal Tumour Society Score (MSTS-93) and the Toronto Extremity Salvage Score (TESS).</p></sec><sec><title>Results</title><p id="Par3">Patients in the combined reconstruction group had higher MSTS-93 and TESS scores (MSTS-93, 83% versus 72%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.023; TESS, 85% versus 74%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.041). The mean 2-year postoperative Insall&#8211;Salvati ratio (ISR), the Blackburne&#8211;Peel index (BPI), and the Caton&#8211;Deschamps index (CDI) for patients who underwent combined reconstruction were 1.18&#8201;&#177;&#8201;0.32, 0.98&#8201;&#177;&#8201;0.22, and 1.21&#8201;&#177;&#8201;0.28, respectively. While, The mean 2-year postoperative ISR, BPI, and CDI of patients without combined reconstruction were 1.42&#8201;&#177;&#8201;0.39, 1.25&#8201;&#177;&#8201;0.29, and 1.61&#8201;&#177;&#8201;0.41, respectively (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). The combined reconstruction group had a lower mean extensor lag (4.3&#176; versus 11.3&#176;, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). In total, 33 patients had at least one complication and 27 patients underwent surgical revision, including 13 infections, 8 local recurrences, 3 soft tissue failures, 2 aseptic loosening, and 1 implant failure. The combined reconstruction group had a lower rate of knee dislocation (2.7% versus 21.4%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.002).</p></sec><sec><title>Conclusions</title><p id="Par4">Soft tissue reconstruction of the proximal tibia using synthetic mesh combined with a medial gastrocnemius flap improves the postoperative efficacy of tumor-related proximal hemiarthroplasty and is expected to reduce the incidence of postoperative knee dislocation and periprosthetic infection.</p></sec><sec><title>Level of evidence</title><p id="Par5">Level III case control study.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Proximal tibial Sarcoma</kwd><kwd>Hemiarthroplasty</kwd><kwd>Medial gastrocnemius flap</kwd><kwd>Soft-tissue reconstruction</kwd><kwd>Complications</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012165</institution-id><institution>Key Technologies Research and Development Program</institution></institution-wrap></funding-source><award-id>2023YFB4706300</award-id><principal-award-recipient><name name-style="western"><surname>Liu</surname><given-names>Weifeng</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>62171017</award-id><award-id>52473310</award-id><principal-award-recipient><name name-style="western"><surname>Zhang</surname><given-names>Qing</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Weifeng</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009331</institution-id><institution>Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support</institution></institution-wrap></funding-source><award-id>ZLRK202507</award-id><principal-award-recipient><name name-style="western"><surname>Liu</surname><given-names>Weifeng</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Societa Italiana di Ortopedia e Traumatologia (Italian Society of Orthopaedics and Traumatology SIOT) 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par6">The proximal tibia is the second most common site for primary bone sarcomas, with 20&#8211;30% of conventional osteosarcomas occurring here [<xref ref-type="bibr" rid="CR1">1</xref>]. Proximal tibial sarcoma resection is most commonly reconstructed with endoprostheses, which provide immediate stability and the fastest weight-bearing. However, the epiphyses on both sides of the knee joint are the most important part of the lower limb for longitudinal growth, accounting for more than two-thirds of lower limb growth [<xref ref-type="bibr" rid="CR2">2</xref>]. Conventional megaprosthesis reconstruction requires resection of the femoral and tibial epiphyses, which can lead to significant leg length discrepancy (LLD) in skeletally immature patients [<xref ref-type="bibr" rid="CR3">3</xref>]. The proximal tibial Hemiarticular endoprosthesis was first used in our center in 2005, and in our previous study we described the clinical results of proximal tibial hemiarthroplasty, which preserves the normal distal femoral epiphysis and reduces the lower length discrepancy [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par7">However, proximal tibial hemiarthroplasty continues to be associated with knee dislocation and limited extension function [<xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>]. Owing to the resection of the periprosthetic ligaments of the knee and previous literature has described multiple strategies to reconstruct soft tissue for extensor function. The ideal reconstruction method of the extensor device remains controversial, and extensor repair methods include direct repair, allograft tissue repair, synthetic ligament repair, and mesh repair [<xref ref-type="bibr" rid="CR9">9</xref>]. Some studies on soft tissue reconstruction of the proximal tibia have used synthetic mesh wrapped prostheses to facilitate tendon reattachment, resulting in improved extensor function. However, most of the current studies are small case series or case reports [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>]. Therefore, we aim to compare the outcomes of synthetic mesh combined with medial gastrocnemius flap in the extensor reconstruction in proximal tibial hemiarthroplasty through a case&#8211;control study.</p><p id="Par8">We reviewed 20&#160;years of experience using hemiarthroplasty to treat bone defects after resection of proximal tibial osteosarcoma in skeletally immature patients. With this study, we sought to answer the following questions of whether patients who underwent reconstruction with a mesh combined medial gastrocnemius muscle flap (1) had better limb function, (2) had improved knee mobility and extensor function, or (3) had lower complication rates.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par9">With institutional review board approval, we retrospectively analyzed the medical records of all patients who underwent Hemiarthroplasty after resection of primary osteosarcoma of the proximal tibia collected at our center between 2005 and 2023. Patient data were prospectively collected and retrieved from the institution&#8217;s sarcoma database. We identified 883 patients with immature tibial bone from the institutional database, of whom 102 underwent hemiarthroplasty after resection of primary osteosarcoma of the tibia.</p><p id="Par10">Patient details are shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. We considered 743&#160;patients with primary malignant bone tumors to be potentially eligible. Of those, 71 patients&#160;were excluded because they underwent amputation. Meanwhile, 562 patients&#160;were excluded joint-preserving endoprosthetic reconstruction, recycled autografts, or extraarticular resection, leaving 110 who met the inclusion criteria for this study. Of those, 8 patients were lost to follow-up, leaving 102 patients for analysis in this study&#160;(Figure. <xref rid="Fig1" ref-type="fig">1</xref>). There were 58 males and 44 females. The mean age at surgery was 11&#160;years (range 7&#8211;14&#160;years) and the average follow-up time was 85&#160;months (12&#8211;233&#160;months). The mean reconstruction length was 15&#160;cm. 98% (100 cases) of the patients received neoadjuvant or adjuvant chemotherapy, and 12% (12 cases) received neoadjuvant or adjuvant radiotherapy. At the last follow-up, 74% (75 cases) of the patients showed no signs of disease, 8% (8 cases) were alive with disease, 18% (18 cases) had died of disease, and 1% (1 case) died of other causes.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Demographics of all patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Characteristic</th><th align="left" colspan="1" rowspan="1">With reconstruction (<italic toggle="yes">n</italic>, %)</th><th align="left" colspan="1" rowspan="1">Without<break/>reconstruction (<italic toggle="yes">n</italic>, %)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> Value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">74 (73%)</td><td align="left" colspan="1" rowspan="1">28 (27%)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Age (mean, yr)</td><td align="left" colspan="1" rowspan="1">11.1 (7&#8211;14)</td><td align="left" colspan="1" rowspan="1">11.4 (9&#8211;14)</td><td char="." align="char" colspan="1" rowspan="1">0.923</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&#8804;&#8201;9&#160;years</td><td align="left" colspan="1" rowspan="1">19</td><td align="left" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">0.601</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&gt;&#8201;9&#160;years</td><td align="left" colspan="1" rowspan="1">55</td><td align="left" colspan="1" rowspan="1">23</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Sex</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.920</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Male</td><td align="left" colspan="1" rowspan="1">39</td><td align="left" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Female</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Pathological diagnosis</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.834</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Osteosarcoma (OS)</td><td align="left" colspan="1" rowspan="1">72</td><td align="left" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Ewings Sarcoma (ES)</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Chondrosarcoma (CS)</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Previous surgery</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Yes</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">0.507</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;No</td><td align="left" colspan="1" rowspan="1">69</td><td align="left" colspan="1" rowspan="1">25</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Surgical margin</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.871</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Wide</td><td align="left" colspan="1" rowspan="1">68</td><td align="left" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Marginal</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Resection length</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.956</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&#8804;&#8201;15&#160;cm</td><td align="left" colspan="1" rowspan="1">48</td><td align="left" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8201;&gt;&#8201;15&#160;cm</td><td align="left" colspan="1" rowspan="1">26</td><td align="left" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Resection length ratio</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.275</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;25&#8211;49%</td><td align="left" colspan="1" rowspan="1">74</td><td align="left" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;50&#8211;74%</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Chemotherapy</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.962</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Yes</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;No</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Radiotherapy</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.887</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Yes</td><td align="left" colspan="1" rowspan="1">66</td><td align="left" colspan="1" rowspan="1">24</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;No</td><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1"/></tr></tbody></table></table-wrap></p><sec id="Sec3"><title>Surgical procedure</title><p id="Par11">Previous studies have described the general surgery and procedural details &#160;(Figure. <xref rid="Fig2" ref-type="fig">2</xref>)[<xref ref-type="bibr" rid="CR4">4</xref>]. All surgeries in both groups were performed by experienced oncological orthopedists (LW, ZQ, and NX). After the tumor is entirely removed, the distal tibia is reamed. Then, two or three sutures (No.5 EXCEL MB66, Ethibond) were passed through the reconstructed hole on the underside of the tibial spacer and sutured to the remaining cruciate ligament. The spacer was fixed to the distal femur with a knot at the bottom of the spacer to reconstruct the cruciate ligament. A double-layer polypropylene artificial patch (Bard&#174;&#160;Soft&#160;Mesh, USA) was taken and sutured to the remaining joint capsule and lateral collateral ligament with sutures (No.2 EXCEL X519, Ethibond). The proximal tibial prosthesis (Lida Kang, Beijing, China) was installed and fixed with bone cement. Depending on the local soft tissue conditions, the length of the prosthesis can be 1.0&#8211;1.5&#160;cm longer than the resection length. Install the tibial prosthesis spacer onto the prosthesis at a 90&#176; knee flexion. The knee is placed in an extended position, the prosthesis is tightly wrapped with an artificial patch, and the prosthesis is fixed by suturing the prosthesis to the reserved hole for fixing the patellar ligament and making the patch integral with the endoprosthesis. The patellar tendon is sutured to the anterior tibial patch. The medial head muscle flap of the gastrocnemius muscle is transferred to cover the front of the endoprosthesis.</p><p id="Par12">Postoperatively, the leg is immobilized in knee extension for 6&#8211;8&#160;weeks using a long leg cast posterior support or a restrictive brace. The isometric muscle contractions were performed during the immobilization period. The patients started passive activities under the supervision of a physiotherapist, and after starting to walk, they were required to wear a support brace Limiting the lateral movement of the knee, ensuring that the knee could only be flexed and extended. Patients were asked to report to the clinic for follow-up visits every 3&#160;months for the first year, every 6&#160;months after 2&#8211;5&#160;years, and annually after 5&#160;years. Conventional anteroposterior, lateral and full-length conventional radiographs of both lower limbs were routinely taken.</p></sec><sec id="Sec4"><title>Outcomes</title><p id="Par13">Our primary study endpoints are function scores and extensor function. Our secondary study endpoints are complication rates. At the final follow-up, 89 patients who had retained the proximal tibial hemiarthroplasty and had been followed up for&#8201;&#8805;&#8201;2&#160;years underwent functional assessment. The functional outcomes are assessed using the Musculoskeletal Tumor Society (MSTS-93) score and the Toronto Extremity Salvage Score (TESS). Patellar Height is determined on a lateral X-ray taken at 30&#176; of flexion using the Insall&#8211;Salvati ratio (ISR), the Blackburne&#8211;Peel index (BPI) and the Caton&#8211;Deschamps index (CDI). Two researchers (LZ, FD) independently examined the ISR, BPI, CDI, extensor lag, and range of motion of the knee&#160;(Figure. <xref rid="Fig3" ref-type="fig">3</xref>). A high patella is defined as a CDI&#8201;&#8805;&#8201;1.2, and a low patella is defined as a CDI&#8201;&#8804;&#8201;0.8. A BlackBurne&#8211;Peel index&#8201;&gt;&#8201;1.0 indicates a high patella, and&#8201;&lt;&#8201;0.5 indicates a low patella. The ISR is the ratio of the patellar tendon length (TL) to the patellar length (PL). A value between 0.8 and 1.2 is considered normal and indicates a normal patella. When the ISR is less than 0.8, it is defined as a low patella. When the ISR is less than 0.8, it is defined as a low patella. The range of motion (ROM) of the knee joint is assessed using a goniometer. Loss of active extension of the knee joint from full extension to the baseline is considered as extension lag. Extension lag&#8201;&gt;&#8201;0 is considered clinically significant. All complications were recorded according to the modified Henderson classification [<xref ref-type="bibr" rid="CR13">13</xref>]. Endoprosthesis removal-free survival is defined as the time from implantation to removal or replacement of the prosthesis&#8217;s main components for any reason.</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par14">Descriptive data is presented as mean&#8201;&#177;&#8201;standard deviation or as numbers and percentages. The normal distribution of the data is checked using the Kolmogorov&#8211;Smirnov test. The mean values of two groups are compared using the paired <italic toggle="yes">t</italic> test or its nonparametric counterpart (Wilcoxon signed-rank test). The mean values of two groups are compared using the independent <italic toggle="yes">t</italic> test or its nonparametric counterpart (Mann&#8211;Whitney <italic toggle="yes">U</italic> test). A two-sided <italic toggle="yes">p</italic>-value&#8201;&lt;&#8201;0.05 was considered significant. Statistical analysis was performed using the Statistical Package for the Social Science (SPSS) software version 26.0 (SPSS Inc., Chicago, IL, USA) and GraphPad Prism software version 10 (GraphPad Software, San Diego, California, USA).</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Endoprosthesis survival and complications</title><p id="Par15">We did not observe a difference in prosthesis survival between the two groups (9.4% versus 10.7%, <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05). In the combined reconstruction group, there were seven patients who had their prosthesis removed, including four cases of amputation after local recurrence, one case of amputation owing to deep infection and two cases of prosthesis removal after infection. In the control group, there were three patients who had their prosthesis removed, including two cases of amputation after local recurrence and one case of prosthesis removal after infection.</p><p id="Par16">In total, 33 patients had 35 complications, and 27 of them underwent revision surgery (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). The most common complications were infection (13%, 13/102) and soft tissue failure (11%, 11/102), followed by local recurrence (8%, 8/102), aseptic loosening (2%, 2/102), and implant failure (1%, 1/102). The combined reconstruction group had a lower rate of knee dislocation (2.7% versus 21.4%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.002) and local infection (8.1% versus 25.0%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.022). However, we did not find a difference in the incidence of other types of complications. After controlling for variables such as age and chemotherapy, we found that a history of previous surgery and not using the medial gastrocnemius muscle flap for reconstruction were independent risk factors for knee subluxation (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Implant failure modes according to the modified Henderson classification system</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Complications</th><th align="left" rowspan="2" colspan="1">Subcategory</th><th align="left" colspan="2" rowspan="1">With reconstruction (<italic toggle="yes">n</italic>&#8201;=&#8201;74)</th><th align="left" colspan="2" rowspan="1">Without reconstruction (<italic toggle="yes">n</italic>&#8201;=&#8201;28)</th><th align="left" rowspan="2" colspan="1"><italic toggle="yes">p</italic> Value</th></tr><tr><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic></th><th align="left" colspan="1" rowspan="1">%</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">n</italic></th><th align="left" colspan="1" rowspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Soft tissue failure</td><td align="left" colspan="1" rowspan="1">1A functional</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2.7%</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">21.4%</td><td char="." align="char" colspan="1" rowspan="1">0.002<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">1B coverage</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2.7%</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">3.6%</td><td char="." align="char" colspan="1" rowspan="1">0.865</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Total</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">5.4%</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">25.0%</td><td char="." align="char" colspan="1" rowspan="1">0.013<sup>*</sup></td></tr><tr><td align="left" rowspan="2" colspan="1">Aseptic loosening</td><td align="left" colspan="1" rowspan="1">2A early (&#8804;&#8201;2 yrs)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td char="." align="char" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">2B late (&gt;&#8201;2 yrs)</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2.7%</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td char="." align="char" colspan="1" rowspan="1">0.380</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Total</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2.7%</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td char="." align="char" colspan="1" rowspan="1">0.380</td></tr><tr><td align="left" rowspan="2" colspan="1">Structural failure</td><td align="left" colspan="1" rowspan="1">3A implant</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td char="." align="char" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">3B bone</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">3.6%</td><td char="." align="char" colspan="1" rowspan="1">0.612</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Total</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0%</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">3.6%</td><td char="." align="char" colspan="1" rowspan="1">0.612</td></tr><tr><td align="left" rowspan="2" colspan="1">Infection</td><td align="left" colspan="1" rowspan="1">4A early (&#8804;&#8201;2 yrs)</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">5.4%</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">21.4%</td><td char="." align="char" colspan="1" rowspan="1">0.015<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">4B late (&gt;&#8201;2 yrs)</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2.7%</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">3.6%</td><td char="." align="char" colspan="1" rowspan="1">0.865</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Total</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">8.1%</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">25.0%</td><td char="." align="char" colspan="1" rowspan="1">0.022<sup>*</sup></td></tr><tr><td align="left" rowspan="2" colspan="1">Tumour progression</td><td align="left" colspan="1" rowspan="1">5A soft tissue</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">5.4%</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">7.3%</td><td char="." align="char" colspan="1" rowspan="1">0.739</td></tr><tr><td align="left" colspan="1" rowspan="1">5B bone</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.4%</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">3.6%</td><td char="." align="char" colspan="1" rowspan="1">0.495</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Total</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">6.8%</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">10.7%</td><td char="." align="char" colspan="1" rowspan="1">0.507</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup><italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, indicating a significant difference between the two groups</p></table-wrap-foot></table-wrap><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p>Multivariate cause-specific cox proportional hazard regression Models for prognostic factors for knee dislocation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Possible risk factors</th><th align="left" colspan="1" rowspan="1">Knee dislocation</th><th align="left" rowspan="2" colspan="1"><italic toggle="yes">p</italic> Value</th></tr><tr><th align="left" colspan="1" rowspan="1">HR<sub>CS</sub>&#160;(95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age&#8201;&#8804;&#8201;9 yrs</td><td align="left" colspan="1" rowspan="1">2.21 (0.32&#8211;12.61)</td><td char="." align="char" colspan="1" rowspan="1">0.64</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex (Male)</td><td align="left" colspan="1" rowspan="1">3.20 (0.44&#8211;7.26)</td><td char="." align="char" colspan="1" rowspan="1">0.23</td></tr><tr><td align="left" colspan="1" rowspan="1">Medial gastrocnemius flaps (Yes)</td><td align="left" colspan="1" rowspan="1">0.14 (0.03&#8211;0.72)</td><td char="." align="char" colspan="1" rowspan="1">0.02<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Previous surgery at same site (yes)</td><td align="left" colspan="1" rowspan="1">10.29 (5.23&#8211;59.31)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Endoprosthesis (modular)</td><td align="left" colspan="1" rowspan="1">0.32 (0.05&#8211;1.92)</td><td char="." align="char" colspan="1" rowspan="1">0.21</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec8"><title>Functional outcomes</title><p id="Par17">At the last follow-up, 89 patients who retained a proximal tibial hemiarticular endoprosthesis were assessed for functional scores&#160;(Figure. <xref rid="Fig4" ref-type="fig">4</xref>). The average MSTS score for patients in the combined reconstruction group was 83&#8201;&#177;&#8201;10% (range: 66&#8211;97%), and 85&#8201;&#177;&#8201;9% (range: 65&#8211;100%) for TESS, and control group was 72&#8201;&#177;&#8201;13% (range: 51&#8211;91%), and 74&#8201;&#177;&#8201;12% (range: 54&#8211;97%) for TESS, respectively (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). Pain and emotional acceptance scores ranged from 4 to 5, and function, support, walking and gait scores ranged from 2 to 5&#160;(Figure. <xref rid="Fig5" ref-type="fig">5</xref>). We found no significant differences between the two groups in pain (<italic toggle="yes">p</italic>&#8201;=&#8201;0.326), emotional acceptance (<italic toggle="yes">p</italic>&#8201;=&#8201;0.397), support (<italic toggle="yes">p</italic>&#8201;=&#8201;0.543) or walking (<italic toggle="yes">p</italic>&#8201;=&#8201;0.235). However, patients with combined reconstruction had higher scores for function and gait (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table&#160;4</label><caption><p>Functional outcome scores and ROM between patients with and without reconstruction</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Subcatogery</th><th align="left" colspan="1" rowspan="1">With reconstruction (<italic toggle="yes">n</italic>&#8201;=&#8201;65)</th><th align="left" colspan="1" rowspan="1">Without reconstruction (<italic toggle="yes">n</italic>&#8201;=&#8201;24)</th><th align="left" rowspan="2" colspan="1">95% CI</th><th align="left" rowspan="2" colspan="1"><italic toggle="yes">p</italic> Value</th></tr><tr><th align="left" colspan="1" rowspan="1">(<italic toggle="yes">n</italic>&#8201;&#177;&#8201;SD, %)</th><th align="left" colspan="1" rowspan="1">(<italic toggle="yes">n</italic>&#8201;&#177;&#8201;SD, %)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">MSTS-93</td><td align="left" colspan="1" rowspan="1">83% (10%)</td><td align="left" colspan="1" rowspan="1">72% (13%)</td><td align="left" colspan="1" rowspan="1">[5%, 17%]</td><td char="." align="char" colspan="1" rowspan="1">0.023<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Pain</td><td align="left" colspan="1" rowspan="1">93% (11%)</td><td align="left" colspan="1" rowspan="1">84% (17%)</td><td align="left" colspan="1" rowspan="1">[&#8722;1%, 15%]</td><td char="." align="char" colspan="1" rowspan="1">0.326</td></tr><tr><td align="left" colspan="1" rowspan="1">Function</td><td align="left" colspan="1" rowspan="1">75% (8%)</td><td align="left" colspan="1" rowspan="1">63% (12%)</td><td align="left" colspan="1" rowspan="1">[6%, 17%]</td><td char="." align="char" colspan="1" rowspan="1">0.033<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Acceptance</td><td align="left" colspan="1" rowspan="1">82% (9%)</td><td align="left" colspan="1" rowspan="1">74% (13%)</td><td align="left" colspan="1" rowspan="1">[&#8722;1%, 10%]</td><td char="." align="char" colspan="1" rowspan="1">0.397</td></tr><tr><td align="left" colspan="1" rowspan="1">Support</td><td align="left" colspan="1" rowspan="1">85% (13%)</td><td align="left" colspan="1" rowspan="1">80% (10%)</td><td align="left" colspan="1" rowspan="1">[&#8722;2%, 13%]</td><td char="." align="char" colspan="1" rowspan="1">0.543</td></tr><tr><td align="left" colspan="1" rowspan="1">Walking</td><td align="left" colspan="1" rowspan="1">77% (10%)</td><td align="left" colspan="1" rowspan="1">70% (13%)</td><td align="left" colspan="1" rowspan="1">[&#8722;1%, 14%]</td><td char="." align="char" colspan="1" rowspan="1">0.235</td></tr><tr><td align="left" colspan="1" rowspan="1">Gait</td><td align="left" colspan="1" rowspan="1">85% (10%)</td><td align="left" colspan="1" rowspan="1">70% (9%)</td><td align="left" colspan="1" rowspan="1">[10%, 19%]</td><td char="." align="char" colspan="1" rowspan="1">0.005<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">TESS</td><td align="left" colspan="1" rowspan="1">85% (9%)</td><td align="left" colspan="1" rowspan="1">74% (12%)</td><td align="left" colspan="1" rowspan="1">[5%, 16%]</td><td char="." align="char" colspan="1" rowspan="1">0.041<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">ROM (&#176;)</td><td align="left" colspan="1" rowspan="1">95&#176;(19&#176;)</td><td align="left" colspan="1" rowspan="1">77&#176;(22&#176;)</td><td align="left" colspan="1" rowspan="1">[7&#176;, 28&#176;]</td><td char="." align="char" colspan="1" rowspan="1">0.012<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Extension lag (&#176;)</td><td align="left" colspan="1" rowspan="1">4.3&#176;(1.2&#176;)</td><td align="left" colspan="1" rowspan="1">11.3&#176;(5.8&#176;)</td><td align="left" colspan="1" rowspan="1">[&#8722;9&#176;, &#8722;4&#176;]</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Preoperative ISR</td><td align="left" colspan="1" rowspan="1">1.01 (0.18)</td><td align="left" colspan="1" rowspan="1">1.03 (0.17)</td><td align="left" colspan="1" rowspan="1">[&#8722;0.10, 0.06]</td><td char="." align="char" colspan="1" rowspan="1">0.856</td></tr><tr><td align="left" colspan="1" rowspan="1">2-year ISR</td><td align="left" colspan="1" rowspan="1">1.18 (0.32)</td><td align="left" colspan="1" rowspan="1">1.42 (0.39)</td><td align="left" colspan="1" rowspan="1">[&#8722;0.42, &#8722;0.06]</td><td char="." align="char" colspan="1" rowspan="1">0.036<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Preoperative BPI</td><td align="left" colspan="1" rowspan="1">0.82 (0.15)</td><td align="left" colspan="1" rowspan="1">0.85 (0.19)</td><td align="left" colspan="1" rowspan="1">[&#8722;0.12, 0.06]</td><td char="." align="char" colspan="1" rowspan="1">0.615</td></tr><tr><td align="left" colspan="1" rowspan="1">2-year BPI</td><td align="left" colspan="1" rowspan="1">0.98 (0.22)</td><td align="left" colspan="1" rowspan="1">1.25 (0.29)</td><td align="left" colspan="1" rowspan="1">[&#8722;0.41, &#8722;0.13]</td><td char="." align="char" colspan="1" rowspan="1">0.028<sup>*</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Preoperative CDI</td><td align="left" colspan="1" rowspan="1">0.97 (0.18)</td><td align="left" colspan="1" rowspan="1">0.99 (0.20)</td><td align="left" colspan="1" rowspan="1">[&#8722;0.11, 0.07]</td><td char="." align="char" colspan="1" rowspan="1">0.736</td></tr><tr><td align="left" colspan="1" rowspan="1">2-year CDI</td><td align="left" colspan="1" rowspan="1">1.21 (0.28)</td><td align="left" colspan="1" rowspan="1">1.61 (0.41)</td><td align="left" colspan="1" rowspan="1">[&#8722;0.55, &#8722;0.25]</td><td char="." align="char" colspan="1" rowspan="1">0.031<sup>*</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>The values are given as the mean percentage of the score with the standard deviation in parentheses</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Knee mobility and extensor function</title><p id="Par18">There was no statistically significant difference between the two groups in preoperative ISR, BPI, and CDI (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05, Table&#160;<xref rid="Tab4" ref-type="table">4</xref>). The mean 2-year postoperative ISR, BPI, and CDI for patients who underwent combined reconstruction were 1.18&#8201;&#177;&#8201;0.32, 0.98&#8201;&#177;&#8201;0.22, and 1.21&#8201;&#177;&#8201;0.28, respectively. Meanwhile, the mean 2-year postoperative ISR, BPI, and CDI of patients without combined reconstruction were 1.42&#8201;&#177;&#8201;0.39, 1.25&#8201;&#177;&#8201;0.29, and 1.61&#8201;&#177;&#8201;0.41, respectively. Patellar height was significantly lower in patients who underwent combined reconstruction compared with those who without combined reconstruction (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).</p><p id="Par19">The mean extensor lag in the combined reconstruction group was 4.3&#8201;&#177;&#8201;1.2&#176;, while the mean extensor lag in the control group was 11.3&#8201;&#177;&#8201;5.8&#176; (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). The mean active knee joint range of motion of the combined reconstruction group was 95&#8201;&#177;&#8201;19&#176; (range: 60&#8211;145&#176;), while the mean active of the control group was 77&#8201;&#177;&#8201;22&#176; (range: 45&#8211;120&#176;, <italic toggle="yes">p</italic>&#8201;=&#8201;0.012).
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table&#160;5</label><caption><p>Summary of comparative literature</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Study</th><th align="left" colspan="1" rowspan="1">Year</th><th align="left" colspan="1" rowspan="1">No</th><th align="left" colspan="1" rowspan="1">Follow-up (months)</th><th align="left" colspan="1" rowspan="1">Patient population</th><th align="left" colspan="1" rowspan="1">Complications</th><th align="left" colspan="1" rowspan="1">MSTS (%)</th><th align="left" colspan="1" rowspan="1">ROM<break/>(&#176;)</th><th align="left" colspan="1" rowspan="1">Extensor lag (&#176;)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><p>Yang</p><p>et al. [<xref ref-type="bibr" rid="CR5">5</xref>]</p></td><td align="left" colspan="1" rowspan="1">2006</td><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">N/A</td><td align="left" colspan="1" rowspan="1">OS (8)</td><td align="left" colspan="1" rowspan="1"><p>Dislocation (1),</p><p>wound necrosis (2),</p><p>fracture (1),</p><p>local recurrence (1)</p></td><td align="left" colspan="1" rowspan="1">N/A</td><td align="left" colspan="1" rowspan="1">N/A</td><td align="left" colspan="1" rowspan="1">N/A</td></tr><tr><td align="left" colspan="1" rowspan="1">Campanacci et al. [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td align="left" colspan="1" rowspan="1">2015</td><td align="left" colspan="1" rowspan="1">19</td><td align="left" colspan="1" rowspan="1">78</td><td align="left" colspan="1" rowspan="1">OS (14), ES (4), Others (1)</td><td align="left" colspan="1" rowspan="1"><p>Infection (1), nonunion (2),</p><p>fracture (6)</p></td><td align="left" colspan="1" rowspan="1">66%</td><td align="left" colspan="1" rowspan="1">N/A</td><td align="left" colspan="1" rowspan="1">N/A</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Chung</p><p>et al. [<xref ref-type="bibr" rid="CR6">6</xref>]</p></td><td align="left" colspan="1" rowspan="1">2015</td><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">83</td><td align="left" colspan="1" rowspan="1">OS (13)</td><td align="left" colspan="1" rowspan="1"><p>Dislocation (3),</p><p>transient peroneal nerve palsy (3),</p><p>implant failure (1),</p><p>infection (2)</p></td><td align="left" colspan="1" rowspan="1">83%</td><td align="left" colspan="1" rowspan="1"><p>62&#176;,</p><p>(40&#8211;110&#176;)</p></td><td align="left" colspan="1" rowspan="1"><p>20&#176;,</p><p>(10&#8211;30&#176;)</p></td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Li</p><p>et al. [<xref ref-type="bibr" rid="CR7">7</xref>]</p></td><td align="left" colspan="1" rowspan="1">2023</td><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">83</td><td align="left" colspan="1" rowspan="1">OS (16)</td><td align="left" colspan="1" rowspan="1"><p>Dislocation (2),</p><p>wound necrosis (1),</p><p>aseptic loosening (2),</p><p>local recurrence (1)</p></td><td align="left" colspan="1" rowspan="1">85%</td><td align="left" colspan="1" rowspan="1">N/A</td><td align="left" colspan="1" rowspan="1">N/A</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Li</p><p>et al. [<xref ref-type="bibr" rid="CR4">4</xref>]</p></td><td align="left" colspan="1" rowspan="1">2024</td><td align="left" colspan="1" rowspan="1">49</td><td align="left" colspan="1" rowspan="1">84</td><td align="left" colspan="1" rowspan="1">OS (49)</td><td align="left" colspan="1" rowspan="1"><p>Dislocation (1),</p><p>wound necrosis (3),</p><p>implant failure (1),</p><p>infection (2),</p><p>local recurrence (6)</p></td><td align="left" colspan="1" rowspan="1">83%</td><td align="left" colspan="1" rowspan="1"><p>82&#176;,</p><p>(30&#8211;135&#176;)</p></td><td align="left" colspan="1" rowspan="1">N/A</td></tr><tr><td align="left" colspan="1" rowspan="1">Current study</td><td align="left" colspan="1" rowspan="1">2024</td><td align="left" colspan="1" rowspan="1">102</td><td align="left" colspan="1" rowspan="1">85</td><td align="left" colspan="1" rowspan="1"><p>OS (97), ES (4),</p><p>CS (1)</p></td><td align="left" colspan="1" rowspan="1"><p>Dislocation (8),</p><p>wound necrosis (3),</p><p>aseptic loosening (2),</p><p>Implant failure (1),</p><p>infection (13),</p><p>local recurrence (8)</p></td><td align="left" colspan="1" rowspan="1">83%</td><td align="left" colspan="1" rowspan="1"><p>95&#176;,</p><p>(60&#8211;145&#176;)</p></td><td align="left" colspan="1" rowspan="1"><p>4.3&#176;,</p><p>(0&#8211;10&#176;)</p></td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec10"><title>Discussion</title><p id="Par20">Proximal tibial hemiarthroplasty is a rare reconstruction method, mainly seen in Asian countries [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>]. This reconstruction method can preserve the distal femoral growth plate and reduce the degree of leg length discrepancy. However, because all the stabilizing structures around the knee joint are removed and there is no hinge structure, the proximal tibial hemiarthroplasty places higher demands on the reconstruction of knee stability. However, there is currently no one optimal soft tissue reconstruction method [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>]. We propose a standardized reconstruction method using a synthetic mesh combined with an medial gastrocnemius flap for soft tissue reconstruction to improve the knee function of the proximal tibial hemiarthroplasty and reduce the complication rate (especially knee dislocation and infection). To the best of our knowledge, this is the largest retrospective study focusing on the soft tissue reconstruction of proximal tibial hemiarthroplasty in skeletally immature patients [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par21">According to previous studies, soft tissue failure (knee dislocation) is the most common mechanical complication of proximal tibial hemiarthroplasty&#160;&#160;(Table. <xref rid="Tab5" ref-type="table">5</xref>) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Chung et al. reported a knee dislocation rate of 23.1% (3/13), which is significantly higher than that of hinged arthroplasty [<xref ref-type="bibr" rid="CR6">6</xref>]. Our study showed a knee dislocation rate of 2.7% in the combined reconstruction group, which is similar to the previously reported dislocation rate in the hinged joint reconstruction group (1&#8211;4%) [<xref ref-type="bibr" rid="CR1">1</xref>]. We believe that several factors have improved the dislocation rate. First, we used ETHIBOND non-absorbable sutures to reconstruct the cruciate ligaments, which can provide sufficient biomechanical strength [<xref ref-type="bibr" rid="CR14">14</xref>]. Zan et al. reported the application of the Ligament Advanced Strengthening System (LARS) to reconstruct the cruciate ligament and internal and external collateral ligaments in eight patients who underwent distal femoral hemiarthroplasty, and no knee dislocations were noted, with a mean MSTS-93 score of 81% [<xref ref-type="bibr" rid="CR15">15</xref>]. However, the technique requires the creation of a tunnel for fixation, which has the potential to interfere with epiphyseal growth, which limits further application of the technique. Second, we sutured the medial and lateral collateral ligaments and patellar tendon to a polypropylene mesh, which is conducive to the growth of fibrous connective tissue and the formation of a soft tissue patch. Finally, we used sutures to fix the medial gastrocnemius flap to the anterior part of the patellar tendon and the surrounding fascia, which further strengthens the anterior stability of the knee joint.<fig id="Fig1" position="float" orientation="portrait"><label>Figure. 1.</label><caption><p>This figure shows the algorithm of patient selection.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="10195_2025_874_Fig1_HTML.jpg"/></fig><fig id="Fig2" position="float" orientation="portrait"><label>Figure.2.</label><caption><p><bold>A</bold> The proximal tibial hemiarticular prosthesis consists of a grouped proximal tibial component and a stemmed prosthesis, both of which are available in different sizes. The top of the custom spacer is concave on both sides to accommodate the femoral condyles and contains three pairs of cruciate Ligament holes for reconstruction. The ACL and PCL are secured using a No. 5 ETHIBOND EXCEL suture. <bold>B</bold> Attachment of spacers to the proximal end of the prosthesis. <bold>C</bold> After prosthesis placement, the prosthesis and mesh are assembled. <bold>D</bold> The medial collateral ligament, the lateral collateral ligament (white arrow) and the patellar tendon (white arrow) were sutured to the mesh, and the patellar ligament ends were reconstructed. <bold>E</bold> The gastrocnemius flap is rotated to cover the anterior portion of the prosthesis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="10195_2025_874_Fig2_HTML.jpg"/></fig><fig id="Fig3" position="float" orientation="portrait"><label>Figure. 3.</label><caption><p><bold>A</bold> Insall&#8211;Salvati ratio (ISR) = A/B, A: length of the longest diagonal of the patella, B: distance from the lower edge of the patella to the patellar tendon stop; <bold>B</bold> Blackburne&#8211;Peel index (BPI) = B/A: a horizontal line drawn at the level of the tibial plateau.A : the line along the patellar articular surface, B: the distance between the horizontal line and the proximal part of the patellar articular surface; <bold>C</bold> Caton&#8211;Deschamps index (CDI) = A/B: A: length of the patellar articular surface, B: distance between the anterior corner of the tibial plateau and the lowermost part of the patellar articular surface.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="10195_2025_874_Fig3_HTML.jpg"/></fig><fig id="Fig4" position="float" orientation="portrait"><label>Figure. 4.</label><caption><p>A 13-year-old female patient diagnosed with osteosarcoma of the right proximal tibia treated with a proximal tibial hemiarthroplasty. <bold>A</bold>, <bold>B</bold> Preoperative X-rays and MRI T2-weighted images showed the extent of proximal tibial osteosarcoma, and <bold>C</bold> 5-year postoperative X-rays showed the prosthesis in good position. <bold>D</bold> Eventually, the affected lower Limb was shortened by 5 mm.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="10195_2025_874_Fig4_HTML.jpg"/></fig><fig id="Fig5" position="float" orientation="portrait"><label>Figure. 5.</label><caption><p>After undergoing reconstruction with proximal tibial resection and hemiarthroplasty with medial gastrocnemius myocutaneous flap and mesh reconstruction, the patients <bold>A</bold>, <bold>B</bold> did not experience extensor lag during full active extension.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO5" position="float" orientation="portrait" xlink:href="10195_2025_874_Fig5_HTML.jpg"/></fig></p><p id="Par22">Consistent with previous studies, our medial gastrocnemius flap reconstruction of the proximal tibia and extensor mechanism provided good functional results. Jentzsch et al. found that high patellar height was associated with extensor lag, increased flexion and a poorer MSTS score [<xref ref-type="bibr" rid="CR14">14</xref>]. We found that both the MSTS and TESS scores improved in the combined reconstruction group, and this improvement was accompanied by a decrease in patellar height and extensor lag. Extensor lag is a common complication of proximal tibial reconstruction [<xref ref-type="bibr" rid="CR6">6</xref>]. Grimer et al. reported an average extensor lag of 30&#176; (0&#8211;90&#176;) in 151 patients who underwent prosthetic reconstruction [<xref ref-type="bibr" rid="CR16">16</xref>]. We believe that reconstructing the extensor is necessary to improve knee range of motion and function. In this study, we fixed the remaining patellar tendon into the hole in the anterior part of the tibia and sutured the edge of the flap to the anterior part of the patellar tendon and the surrounding fascia. Our results showed that the knee function score improved in the combined reconstruction group with reduced patellar height and extensor lag. He et al. showed that postoperative ISR was negatively correlated with MSTS scores (function, gait, walking), and that postoperative ISR was significantly correlated with knee extension lag [<xref ref-type="bibr" rid="CR17">17</xref>]. We used three patellar height assessment indicators (ISR, BPI, CDI) and found that the postoperative patellar height in the combined reconstruction group improved, indicating that this reconstruction method can improve patellar position and extensor lag.</p><p id="Par23">Infection is a common complication after proximal tibial replacement in most series (3&#8211;23%) [<xref ref-type="bibr" rid="CR18">18</xref>]. Previous studies have demonstrated a reduction in infection rates after soft tissue reconstruction using an medial gastrocnemius flap, which was confirmed in our study. In addition, we found a reduction in early infection rates in the combined reconstruction group, suggesting that adequate soft tissue coverage is necessary to prevent early infection. However, this reduction may also be due to other changes or increased experience during the study period. Moreover, we did not find a difference in late infection rates between the two groups.</p><p id="Par24">Our study has some limitations. First, because this reconstruction is rare and only large-scale case follow-ups are available in Asian countries, its general effectiveness in people of different ethnicities has not yet been proven. Second, we believe that the improvement in functional outcomes should be partly attributed to increased surgical experience with this reconstruction technique. In addition, the subpatellar/pseudopatinellar cut-off points were adopted from standard total knee arthroplasty because they have not yet been defined for EPR. However, we may have added supplementary information by measuring different patellar height indices (ISR, BPI, CDI), which best reflect the extensor mechanism. Apart from this, we included all patients undergoing proximal Hemiarthroplasty, so our design largely avoided selection bias. Finally, ROM and patellar Height were measured and recorded separately by two highly experienced doctors, which provided consistency over the 20-year study period but also introduced the possibility of bias.</p><p id="Par25">In conclusion, soft tissue reconstruction of the proximal tibial hemiarticular prosthesis using a synthetic patch in conjunction with a medial gastrocnemius flap is an effective technological modification that restores the physiologic anatomy of the ligaments and provides effective coverage of the prosthesis. Patients who received a proximal tibial hemiarthroplasty with soft tissue reconstruction using a mesh combined with an medial gastrocnemius flap had a greater range of motion, better knee function and a reduced extensor lag. Therefore, on the basis of our results, we now recommend routine use of a mesh combined with an medial gastrocnemius flap for soft tissue reconstruction in patients undergoing proximal tibial hemiarthroplasty.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Zhuoyu Li and Jilong Zhao contributed equally to this paper, Weifeng Liu and Qing Zhang are co-corresponding authors.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by the National Key R&amp;D Program of China Grant No (2023YFB4706300), National Natural Science Foundation of China (52473310,62171017), Beijing Natural Science Foundation (L252065,7244514), and Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (ZLRK202507).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Z.L. carried out writing&#8212;original draft; D.F., J.Z., Y.Y., and J.T. carried out data curation; Z.D. writing&#8212;review and editing; Q.Z. and X.N. carried out supervision; W.L. carried out study conceptualization and supervision.&#160;Zhuoyu Li and Jilong Zhao contributed equally to this paper. Weifeng Liu and Qing Zhang are co-corresponding authors.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data used in this study are not publicly available because of patient confidentiality but are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par26">The studies involving human participants were reviewed and approved by the Ethics Committee of Beijing Jishuitan Hospital (J2024-006). Informed consents were obtained from all subjects or guardians.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interest</title><p id="Par27">Each author certifies that neither he nor she, nor any of his or her immediate family members, has funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Summers</surname><given-names>SH</given-names></name><name name-style="western"><surname>Zachwieja</surname><given-names>EC</given-names></name><name name-style="western"><surname>Butler</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Mohile</surname><given-names>NV</given-names></name><name name-style="western"><surname>Pretell-Mazzini</surname><given-names>J</given-names></name></person-group><article-title>Proximal tibial reconstruction after tumor resection: a systematic review of the literature</article-title><source>JBJS Rev</source><year>2019</year><volume>7</volume><issue>7</issue><fpage>e1</fpage><pub-id pub-id-type="doi">10.2106/JBJS.RVW.18.00146</pub-id><pub-id pub-id-type="pmid">31268862</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Summers SH, Zachwieja EC, Butler AJ, Mohile NV, Pretell-Mazzini J (2019) Proximal tibial reconstruction after tumor resection: a systematic review of the literature. JBJS Rev 7(7):e1<pub-id pub-id-type="pmid">31268862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.RVW.18.00146</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shapiro</surname><given-names>F</given-names></name></person-group><article-title>Developmental patterns in lower-extremity length discrepancies</article-title><source>J Bone Joint Surg Am</source><year>1982</year><volume>64</volume><issue>5</issue><fpage>639</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.2106/00004623-198264050-00001</pub-id><pub-id pub-id-type="pmid">7085690</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Shapiro F (1982) Developmental patterns in lower-extremity length discrepancies. J Bone Joint Surg Am 64(5):639&#8211;651<pub-id pub-id-type="pmid">7085690</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>CD</given-names></name><name name-style="western"><surname>Wustrack</surname><given-names>RL</given-names></name><name name-style="western"><surname>Levin</surname><given-names>AS</given-names></name></person-group><article-title>Limb-Salvage options in growing children with malignant bone tumors of the lower extremity: a critical analysis review</article-title><source>JBJS Rev</source><year>2017</year><volume>5</volume><issue>7</issue><fpage>e7</fpage><pub-id pub-id-type="doi">10.2106/JBJS.RVW.16.00026</pub-id><pub-id pub-id-type="pmid">28742715</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Morris CD, Wustrack RL, Levin AS (2017) Limb-Salvage options in growing children with malignant bone tumors of the lower extremity: a critical analysis review. JBJS Rev 5(7):e7<pub-id pub-id-type="pmid">28742715</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.RVW.16.00026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Survival and functional outcomes after hemiarthroplasty in children with proximal tibial osteosarcoma</article-title><source>J Orthop Surg Res</source><year>2024</year><volume>19</volume><issue>1</issue><fpage>619</fpage><pub-id pub-id-type="doi">10.1186/s13018-024-05103-1</pub-id><pub-id pub-id-type="pmid">39358763</pub-id><pub-id pub-id-type="pmcid">PMC11448014</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Li Y, Xu H, Yang Y et al (2024) Survival and functional outcomes after hemiarthroplasty in children with proximal tibial osteosarcoma. J Orthop Surg Res 19(1):619<pub-id pub-id-type="pmid">39358763</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13018-024-05103-1</pub-id><pub-id pub-id-type="pmcid">PMC11448014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>RL</given-names></name><name name-style="western"><surname>Xu</surname><given-names>WP</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><etal/></person-group><article-title>Semi-joint prosthesis replacement in the treatment of children&#8217;s malignant tumors around the knee[J]</article-title><source>Chin J Bone Tumor and Bone Disease</source><year>2005</year><volume>4</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Yang RL, Xu WP, Guo W et al (2005) Semi-joint prosthesis replacement in the treatment of children&#8217;s malignant tumors around the knee[J]. Chin J Bone Tumor and Bone Disease 4(1):1&#8211;4</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>SH</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>DG</given-names></name><name name-style="western"><surname>Cho</surname><given-names>WH</given-names></name><name name-style="western"><surname>Song</surname><given-names>WS</given-names></name><name name-style="western"><surname>Kong</surname><given-names>CB</given-names></name><name name-style="western"><surname>Cho</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>BS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SY</given-names></name></person-group><article-title>Temporary hemiarthroplasty with a synthetic device in children with osteosarcoma around the knee as a bridging procedure until skeletal maturity</article-title><source>J Surg Oncol</source><year>2015</year><volume>112</volume><issue>1</issue><fpage>107</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1002/jso.23964</pub-id><pub-id pub-id-type="pmid">26179818</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Chung SH, Jeon DG, Cho WH, Song WS, Kong CB, Cho SH, Kim BS, Lee SY (2015) Temporary hemiarthroplasty with a synthetic device in children with osteosarcoma around the knee as a bridging procedure until skeletal maturity. J Surg Oncol 112(1):107&#8211;114<pub-id pub-id-type="pmid">26179818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jso.23964</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Ji</surname><given-names>T</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><name name-style="western"><surname>Qu</surname><given-names>H</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Outcomes of semiknee replacement in skeletally immature bone sarcoma patients</article-title><source>J Knee Surg</source><year>2023</year><volume>36</volume><issue>10</issue><fpage>1052</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1055/s-0042-1748823</pub-id><pub-id pub-id-type="pmid">35817056</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Li D, Ji T, Guo W, Qu H, Liang H, Yang Y, Tang X, Yang R, Wang J (2023) Outcomes of semiknee replacement in skeletally immature bone sarcoma patients. J Knee Surg 36(10):1052&#8211;1059<pub-id pub-id-type="pmid">35817056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0042-1748823</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campanacci</surname><given-names>L</given-names></name><name name-style="western"><surname>Al&#236;</surname><given-names>N</given-names></name><name name-style="western"><surname>Casanova</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kreshak</surname><given-names>J</given-names></name><name name-style="western"><surname>Manfrini</surname><given-names>M</given-names></name></person-group><article-title>Resurfaced allograft-prosthetic composite for proximal tibial reconstruction in children: intermediate-term results of an original technique</article-title><source>J Bone Joint Surg Am</source><year>2015</year><volume>97</volume><issue>3</issue><fpage>241</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.2106/JBJS.N.00447</pub-id><pub-id pub-id-type="pmid">25653325</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Campanacci L, Al&#236; N, Casanova JM, Kreshak J, Manfrini M (2015) Resurfaced allograft-prosthetic composite for proximal tibial reconstruction in children: intermediate-term results of an original technique. J Bone Joint Surg Am 97(3):241&#8211;250<pub-id pub-id-type="pmid">25653325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.N.00447</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cipriano</surname><given-names>CA</given-names></name><name name-style="western"><surname>Dalton</surname><given-names>J</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>DJ</given-names></name></person-group><article-title>Does patellar tendon repair with Gastrocnemius flap augmentation effectively restore active extension after proximal tibial sarcoma resection?</article-title><source>Clin Orthop Relat Res</source><year>2019</year><volume>477</volume><issue>3</issue><fpage>584</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1097/CORR.0000000000000564</pub-id><pub-id pub-id-type="pmid">30461516</pub-id><pub-id pub-id-type="pmcid">PMC6382189</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Cipriano CA, Dalton J, McDonald DJ (2019) Does patellar tendon repair with Gastrocnemius flap augmentation effectively restore active extension after proximal tibial sarcoma resection? Clin Orthop Relat Res 477(3):584&#8211;593<pub-id pub-id-type="pmid">30461516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CORR.0000000000000564</pub-id><pub-id pub-id-type="pmcid">PMC6382189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Browne</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hanssen</surname><given-names>AD</given-names></name></person-group><article-title>Reconstruction of patellar tendon disruption after total knee arthroplasty: results of a new technique utilizing synthetic mesh</article-title><source>J Bone Joint Surg Am</source><year>2011</year><volume>93</volume><fpage>1137</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.2106/JBJS.J.01036</pub-id><pub-id pub-id-type="pmid">21776550</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Browne JA, Hanssen AD (2011) Reconstruction of patellar tendon disruption after total knee arthroplasty: results of a new technique utilizing synthetic mesh. J Bone Joint Surg Am 93:1137&#8211;1143<pub-id pub-id-type="pmid">21776550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.J.01036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichikawa</surname><given-names>J</given-names></name><name name-style="western"><surname>Matsumoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Shimoji</surname><given-names>T</given-names></name><name name-style="western"><surname>Ae</surname><given-names>K</given-names></name><name name-style="western"><surname>Tanizawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Gokita</surname><given-names>T</given-names></name></person-group><article-title>A new technique using mesh for extensor reconstruction after proximal tibial resection</article-title><source>Knee</source><year>2015</year><volume>22</volume><fpage>659</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/j.knee.2015.01.001</pub-id><pub-id pub-id-type="pmid">26003215</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Ichikawa J, Matsumoto S, Shimoji T, Ae K, Tanizawa T, Gokita T (2015) A new technique using mesh for extensor reconstruction after proximal tibial resection. Knee 22:659&#8211;663<pub-id pub-id-type="pmid">26003215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.knee.2015.01.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levin</surname><given-names>AS</given-names></name><name name-style="western"><surname>Arkader</surname><given-names>A</given-names></name><name name-style="western"><surname>Morris</surname><given-names>CD</given-names></name></person-group><article-title>Reconstruction following tumor resections in skeletally immature patients</article-title><source>J Am Acad Orthop Surg</source><year>2017</year><volume>25</volume><issue>3</issue><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.5435/JAAOS-D-15-00619</pub-id><pub-id pub-id-type="pmid">28195984</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Levin AS, Arkader A, Morris CD (2017) Reconstruction following tumor resections in skeletally immature patients. J Am Acad Orthop Surg 25(3):204&#8211;213<pub-id pub-id-type="pmid">28195984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5435/JAAOS-D-15-00619</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henderson</surname><given-names>ER</given-names></name><name name-style="western"><surname>O&#8217;Connor</surname><given-names>MI</given-names></name><name name-style="western"><surname>Ruggieri</surname><given-names>P</given-names></name><name name-style="western"><surname>Windhager</surname><given-names>R</given-names></name><name name-style="western"><surname>Funovics</surname><given-names>PT</given-names></name><name name-style="western"><surname>Gibbons</surname><given-names>CL</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><name name-style="western"><surname>Hornicek</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Temple</surname><given-names>HT</given-names></name><name name-style="western"><surname>Letson</surname><given-names>GD</given-names></name></person-group><article-title>Classification of failure of limb salvage after reconstructive surgery for bone tumours : a modified system Including biological and expandable reconstructions</article-title><source>Bone Joint J</source><year>2014</year><volume>96</volume><issue>11</issue><fpage>1436</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.96B11.34747</pub-id><pub-id pub-id-type="pmid">25371453</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Henderson ER, O&#8217;Connor MI, Ruggieri P, Windhager R, Funovics PT, Gibbons CL, Guo W, Hornicek FJ, Temple HT, Letson GD (2014) Classification of failure of limb salvage after reconstructive surgery for bone tumours&#8239;: a modified system Including biological and expandable reconstructions. Bone Joint J 96(11):1436&#8211;1440<pub-id pub-id-type="pmid">25371453</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/0301-620X.96B11.34747</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jentzsch</surname><given-names>T</given-names></name><name name-style="western"><surname>Erschbamer</surname><given-names>M</given-names></name><name name-style="western"><surname>Seeli</surname><given-names>F</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>B</given-names></name></person-group><article-title>Extensor function after medial gastrocnemius flap reconstruction of the proximal tibia</article-title><source>Clin Orthop Relat Res</source><year>2013</year><volume>471</volume><issue>7</issue><fpage>2333</fpage><lpage>2339</lpage><pub-id pub-id-type="doi">10.1007/s11999-013-2851-8</pub-id><pub-id pub-id-type="pmid">23423620</pub-id><pub-id pub-id-type="pmcid">PMC3676620</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Jentzsch T, Erschbamer M, Seeli F, Fuchs B (2013) Extensor function after medial gastrocnemius flap reconstruction of the proximal tibia. Clin Orthop Relat Res 471(7):2333&#8211;2339<pub-id pub-id-type="pmid">23423620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11999-013-2851-8</pub-id><pub-id pub-id-type="pmcid">PMC3676620</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zan</surname><given-names>P</given-names></name><name name-style="western"><surname>Shen</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Custom-made semi-joint prosthesis replacement combined ligament advanced reinforcement system (LARS) ligament reconstruction for the limb salvage surgery of malignant tumors in the distal femur in skeletal immature children</article-title><source>Front Pediatr</source><year>2023</year><volume>11</volume><fpage>1168637</fpage><pub-id pub-id-type="doi">10.3389/fped.2023.1168637</pub-id><pub-id pub-id-type="pmid">37416814</pub-id><pub-id pub-id-type="pmcid">PMC10320852</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Zan P, Shen J, Liu K et al (2023) Custom-made semi-joint prosthesis replacement combined ligament advanced reinforcement system (LARS) ligament reconstruction for the limb salvage surgery of malignant tumors in the distal femur in skeletal immature children. Front Pediatr 11:1168637<pub-id pub-id-type="pmid">37416814</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fped.2023.1168637</pub-id><pub-id pub-id-type="pmcid">PMC10320852</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grimer</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Carter</surname><given-names>SR</given-names></name><name name-style="western"><surname>Tillman</surname><given-names>RM</given-names></name><name name-style="western"><surname>Sneath</surname><given-names>RS</given-names></name><name name-style="western"><surname>Walker</surname><given-names>PS</given-names></name><name name-style="western"><surname>Unwin</surname><given-names>PS</given-names></name><name name-style="western"><surname>Shewell</surname><given-names>PC</given-names></name></person-group><article-title>Endoprosthetic replacement of the proximal tibia</article-title><source>J Bone Joint Surg Br</source><year>1999</year><volume>81</volume><fpage>488</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.81B3.0810488</pub-id><pub-id pub-id-type="pmid">10872373</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Grimer RJ, Carter SR, Tillman RM, Sneath RS, Walker PS, Unwin PS, Shewell PC (1999) Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg Br 81:488&#8211;494<pub-id pub-id-type="pmid">10872373</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/0301-620x.81b3.9234</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>F</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Patellar height influences knee function in patients with aggressive bone tumors of the proximal tibia after endoprosthetic reconstruction</article-title><source>Knee</source><year>2018</year><volume>25</volume><issue>5</issue><fpage>952</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1016/j.knee.2018.07.008</pub-id><pub-id pub-id-type="pmid">30108009</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">He F, Hu C, Shen Y et al (2018) Patellar height influences knee function in patients with aggressive bone tumors of the proximal tibia after endoprosthetic reconstruction. Knee 25(5):952&#8211;958<pub-id pub-id-type="pmid">30108009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.knee.2018.07.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeys</surname><given-names>LM</given-names></name><name name-style="western"><surname>Grimer</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Carter</surname><given-names>SR</given-names></name><name name-style="western"><surname>Tillman</surname><given-names>RM</given-names></name></person-group><article-title>Periprosthetic infection in patients treated for an orthopaedic oncological condition</article-title><source>J Bone Joint Surg Am</source><year>2005</year><volume>87</volume><issue>4</issue><fpage>842</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.2106/00004623-200504000-00021</pub-id><pub-id pub-id-type="pmid">15805215</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am 87(4):842&#8211;849<pub-id pub-id-type="pmid">15805215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.C.01222</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>